Mechanism of action
The drug affects the peripheral nervous system, purposefully regulating its functions and interaction with effector organs due to its chemical structure and pharmacodynamic properties.
Pharmacological effects
The action of Methacinum aims to regulate the autonomic functions of the body. The drug provides the required therapeutic response from peripheral nerve structures by blocking or stimulating impulse transmission depending on the clinical task.
Indications for use
The drug is prescribed as part of combination therapy for conditions requiring pharmacological regulation of peripheral nervous system functions, in accordance with the recommendations of specialized guidelines and clinical protocols.
Side effects and safety
When using the drug, it is essential to strictly follow the dosage regimen. Exceeding the maximum single doses (MRD) and maximum daily doses (MSD) is unacceptable, as this can lead to adverse drug reactions. The physician should consider the routes of administration: for oral administration, the maximum daily dose is 0.015 g, and for parenteral administration (IV, IM, SC) it is 0.006 g.
Administration and dosing details
Methacinum is available in two main dosage forms: tablets (0.001 g and 0.002 g dosages) and injection solution (0.1%, 1 ml in ampoules). It is prescribed orally at 0.002–0.004 g 2–3 times a day. Parenterally (intravenously, intramuscularly, or subcutaneously), it is administered at 0.5–2 ml of a 0.1% solution. It is important to remember the maximum dose values: single oral dose — 0.005 g, daily oral dose — 0.015 g, daily parenteral dose — 0.006 g.
Briefly: answers to topical questions
To which specific pharmacological group and subgroup does methocinium iodide belong?
Methocinium iodide (referred to in sources as metacin) belongs to the pharmacological group of muscarinic acetylcholine receptor antagonists (anticholinergics). Within this classification, it is included in the subgroup of synthetic agents. By chemical structure, it is a quaternary ammonium compound that exerts a predominantly peripheral effect. Metacin is used to relax smooth muscle, induce tocolysis, and suppress unwanted vagal reactions during premedication.
For which specific diseases and conditions is the use of methocinium iodide indicated?
The drug is used to treat spastic conditions and suppress vagal reactions. Indications for the use of metacin include:
- Smooth muscle spasms — gastrointestinal spasms, as well as hepatic and renal colic.
- Bronchial asthma.
- Tocolysis.
- Premedication before anesthesia and suppression of vagal reactions.
Does methocinium iodide cross the blood-brain barrier and affect the central nervous system?
Methocinium iodide does not cross the blood-brain barrier and exerts only a peripheral effect. The drug belongs to quaternary ammonium compounds. Unlike tertiary amines such as atropine and scopolamine, which are capable of crossing the blood-brain barrier and causing central effects, metacin has no central action.
How does methocinium iodide differ from atropine in chemical structure and pharmacodynamics?
The main differences lie in their origin, chemical structure, and ability to penetrate the central nervous system.
| Characteristic | Atropine | Metacin |
|---|---|---|
| Origin | Natural drug | Synthetic drug |
| Chemical structure | Tertiary amine | Quaternary compound |
| Blood-brain barrier (BBB) penetration | Crosses the BBB | Does not cross the BBB |
| Pharmacodynamics | Produces central effects (excitation) | Peripheral action only |
Both drugs are antimuscarinics and are used for premedication, but metacin is additionally used for tocolysis, whereas atropine serves as an antidote for muscarinic agonist poisoning.
Metacin — one step to the periphery: tablet or ampoule under strict control of maximum doses (0.015 orally / 0.006 parenterally).
Class and exam questions
What are the main dosage forms of Methocinium iodide?
The drug is available as tablets of 0.001 and 0.002 g, as well as a 0.1% solution in 1 ml ampoules.
What is the maximum daily dose of the drug when taken orally?
The maximum daily dose (MSD) for oral administration is 0.015 g, and the maximum single dose (MRD) is 0.005 g.
How is Methocinium iodide administered parenterally?
Parenterally, the drug is administered intravenously, intramuscularly, or subcutaneously at 0.5–2 ml of a 0.1% solution, with the maximum daily dose being 0.006 g.
What else to study on this topic
- Pharmacodynamics of agents affecting the peripheral nervous system
- Rules for calculating maximum doses (MRD and MSD) in prescription writing
- Comparison of oral and parenteral routes of drug administration
- Toxicological profile and management of overdose
- Pharmacokinetics of ampoule and tablet formulations
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Methocinium iodide» and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the «Drugs and Prescriptions» section
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.